Nasdaq


SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market

May 27th, 2022 - Ryan Allway

TEL AVIV, Israel, May 27, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that it entered into a securities purchase agreement with a single healthcare-focused institutional investor for aggregate gross […]

Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ

May 23rd, 2022 - Ryan Allway

Ehave owns approximately 9,793,754 shares of Mycotopia Therapies valued at more than $24 million, as of Friday’s closing price; Plans partial distribution to shareholders   MIAMI, May 23, 2022 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today that its Mycotopia Therapies (OTC: TPIA) subsidiary has signed a definitive […]

Akanda Corp. Announces Pricing of Initial Public Offering and Expects To Commence Trading on NASDAQ Tomorrow

March 14th, 2022 - Ryan Allway

Common Shares of Akanda will trade on the NASDAQ under ticker symbol AKAN All Figures in US Dollars Unless Otherwise Stated   TORONTO, March 14, 2022 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today congratulates Akanda Corp. (“Akanda”) (NASDAQ: AKAN), an international medical cannabis company, on the pricing of […]

22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation

February 23rd, 2022 - Ryan Allway

New Capabilities Allow 22nd Century to Accelerate Revenue Streams and Create Higher Value Commercial Lines BUFFALO, N.Y., Feb. 23, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today, together with its […]

CEA Industries Announces Pricing of $24 Million Public Offering and Nasdaq Listing

February 10th, 2022 - Ryan Allway

Louisville, Colorado, Feb. 10, 2022 (GLOBE NEWSWIRE) — CEA Industries Inc. (NASDAQ: CEAD, CEADW) (the “Company”), a leader in controlled environment agriculture (CEA) systems engineering and technologies, today announced the pricing of an underwritten public offering of 5,811,138 shares of the Company’s common stock and warrants to purchase up to 5,811,138 shares of the Company’s common stock […]

Silver Spike Investment Corp. Prices Initial Public Offering

February 4th, 2022 - Ryan Allway

NEW YORK, February 04, 2022–(BUSINESS WIRE)–Silver Spike Investment Corp. (“SSIC”), a newly-organized closed-end management investment company that has elected to be treated as a business development company, today announced that it priced its initial public offering of 6,071,429 shares of its common stock at $14.00 per share. Shares of common stock of SSIC are expected […]

Leafly and Merida Merger Corp. I Announce Closing of Business Combination

February 4th, 2022 - Ryan Allway

Leafly’s common stock to begin trading on NASDAQ on Monday, February 7, 2022, with ticker symbol LFLY Transaction strengthens Leafly’s position as a leading online cannabis discovery marketplace   SEATTLE & NEW YORK, February 04, 2022–(BUSINESS WIRE)–Leafly Holdings Inc. (“Leafly” or the “Company”), a leading online cannabis discovery marketplace and resource for cannabis consumers, and […]

Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders

January 24th, 2022 - Ryan Allway

SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a “Pure Play” Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier Pharmaceuticals   JUPITER, FL / ACCESSWIRE / January 24, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it intends to dividend its wholly-owned subsidiary, SRM Entertainment to […]

Silver Spike Investment Corp. Announces Proposed Initial Public Offering

January 18th, 2022 - Ryan Allway

NEW YORK, January 18, 2022–(BUSINESS WIRE)–Silver Spike Investment Corp. (“SSIC”), a newly-organized closed-end management investment company that has elected to be treated as a business development company, plans to make an initial public offering of 8,928,572 shares of its common stock. The price for the offering is $14.00 per share of common stock. SSIC is […]

SciSparc Provides Updates Upon Conclusion of 2021

December 29th, 2021 - Ryan Allway

TEL AVIV, Israel, Dec. 29, 2021 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today provides updates regarding its activities in 2021.   SciSparc Ltd. Logo (PRNewsfoto/SciSparc Ltd.) Itzhak Shrem, Chairman of the board of SciSparc, […]

SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market

December 20th, 2021 - Ryan Allway

TEL AVIV, Israel, Dec. 20, 2021 /PRNewswire/ — SciSparc Ltd. (OTCQB: SPRCF) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced that its ordinary shares have been approved for listing on The Nasdaq Capital Market (“Nasdaq”) under the symbol “SPRC”. Trading […]

COMPASS Selected for Addition to NASDAQ Biotechnology Index

December 7th, 2021 - Ryan Allway

London, U.K., Dec. 17, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced it has been selected for addition to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective as of market open on Monday, December 20, 2021. The […]

High Tide Announces At-The-Market Facility of up to CAD$40,000,000 for Strategic Initiatives

December 6th, 2021 - Ryan Allway

CALGARY, AB, Dec. 6, 2021 /CNW/ – High Tide Inc. (“High Tide” or the “Company“) (TSXV: HITI) (NASDAQ: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks and mortar as well as global e-commerce assets, is pleased to announce it has established an at-the-market equity offering program (the “ATM Program“) that allows the Company to issue up to CAD$40 […]

Clearmind Medicine to Pursue Dual Listing on Nasdaq

November 22nd, 2021 - Ryan Allway

Toronto, Ontario, Nov. 22, 2021 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announced that its board of directors has decided to pursue a dual listing […]

Leafly To Go Public Through Business Combination With Merida Merger Corp I

August 9th, 2021 - Ryan Allway

Transaction Enables Leafly to Execute Growth Strategy and Expand Leading Content-First, Community-Driven Cannabis Discovery Marketplace Leafly is Well Positioned to Capitalize on Accelerating Legalization Trends Across North America CEO Yoko Miyashita and Current Management Team will Continue to Lead the Company Post-Closing Existing Shareholders to Roll 100% of Their Existing Stake into the Combined Company […]

22nd Century Group to Begin Trading on Nasdaq on August 16, 2021

August 5th, 2021 - Ryan Allway

BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved for uplisting to the Nasdaq Capital Market effective as of the market open on August 16, 2021. […]

New CBD Trials Point the Way for Enveric, MagicMed

July 30th, 2021 - Ryan Allway

  As the cannabis industry strives to gain widespread acceptance in the mainstream, scientific studies into the potential benefits of the plant and its active ingredients play a key role in reaching that goal. There are currently very few approved pharmaceutical drug applications for cannabinoids, but that could change. After decades of effective prohibition there […]

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

July 27th, 2021 - Ryan Allway

TORONTO, July 27, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip” or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today that it has received final approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its common shares on the NASDAQ […]

High Tide Begins Trading on Nasdaq Today Under Symbol “HITI”

June 2nd, 2021 - Ryan Allway

High Tide becomes the first major publicly traded cannabis retailer to trade on the Nasdaq. Listing highlights High Tide’s broad cannabis ecosystem, positioning the Company to attract larger M&A opportunities in Canada, the U.S. and beyond. The Company’s updated investor presentation is now available at hightideinc.com.   CALGARY, June 2, 2021 /CNW/ – High Tide […]

Nasdaq Approves High Tide’s Application to List

May 28th, 2021 - Ryan Allway

High Tide becomes the first major publicly traded cannabis retailer to announce it has been approved to trade on Nasdaq. High Tide shares expected to begin trading on Nasdaq on June 2nd, 2021 High Tide has received approval from Nasdaq to list its common shares for trading under the symbol “HITI”   CALGARY, May 28th, […]

SHG Obtains Conditional Approval to List on NASDAQ Under the Symbol “SLHG”

May 13th, 2021 - Ryan Allway

TORONTO, ON – May 13, 2021 – Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that the Company has received conditional approval from The Nasdaq Stock Market LLC ( “Nasdaq”) to list its issued and outstanding common shares on […]

High Tide Announces Details of Consolidation to Meet NASDAQ Listing Requirements

May 12th, 2021 - Ryan Allway

15:1 share consolidation to begin trading on or about May 14, 2021 NASDAQ Capital Market listing expected in May 2021 under ticker symbol HITI   CALGARY, AB, May 12, 2021 /CNW/ – High Tide Inc. (“High Tide” or the “Company“) (TSXV: HITI) (OTCQB: HITIF) (FRA: 2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce […]

Flora Growth Corp. Announces Pricing of Initial Public Offering

May 11th, 2021 - Ryan Allway

TORONTO, ONTARIO – May 11, 2021 — Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, today announced the pricing of its initial public offering of 3,333,333 shares of its common stock, at the high end of the proposed price range of US$5.00 per share to the public […]

The Valens Company Submits Application to List on Nasdaq

April 28th, 2021 - Ryan Allway

KELOWNA, BC, April 28, 2021 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a leading manufacturer of cannabis products, is pleased to announce that it has submitted an initial application to list its common shares (“Shares”) on the Nasdaq Capital Market (“Nasdaq”).   “We have taken a significant step forward in achieving one […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading